Clinical trial
An Extension of Istradefylline in North American Parkinson's Disease Patients…
NCT00199381 · Kyowa Kirin, Inc., Industry · Terminated
Key facts
| NCT number | NCT00199381 |
|---|---|
| Title | An Extension of Istradefylline in North American Parkinson's Disease Patients Who Have Completed Study 6002-INT-001 |
| Official title | An Open-Label Multicenter Study of the Continued Safety of Istradefylline (KW-6002) In Subjects With Parkinson's Disease Who Have Recently Completed One Year of Treatment With Istradefylline. |
| Lead sponsor | Kyowa Kirin, Inc., Industry |
| Collaborators | Kyowa Kirin Co., Ltd. Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Parkinson's Disease |
| Intervention type | Drug |
| Interventions | Istradefylline |
| Enrollment | 504 |
| Start date | Oct 1, 2005 |
| Primary completion | Oct 1, 2008 |
| Completion | Oct 1, 2008 |
| First posted | Sep 20, 2005 |
| Last update posted | May 17, 2024 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: